Where spectrin snuggles with ankyrin ----------------------------------------------------------------------------------------------------------------Philip S. Low PURDUE UNIVERSITY
Using the crystal structure of ␤-spectrin repeats 14 and 15 that bind ankyrin, together with a crystal structure of a fragment of ankyrin that binds spectrin, and detailed site-directed mutagenesis, Stabach and Ipsaro and their respective colleagues analyze for the first time the structure of the ankyrin-␤-spectrin bridge that connects band 3 (AE1) and other proteins to the membrane skeleton.
A nkyrin forms bridges that connect membrane-spanning proteins to an underlying spectrinbased membrane skeleton. These bridges not only contribute critically to membrane stability, but also ensure the proper lateral distribution of membrane-spanning proteins, the assembly of signaling and structural components at the inner membrane surface, the guided trafficking of endosomes and organelles in nucleated cells, and the regulation of membrane functions by mechanical stresses. 1 In erythrocytes, the spectrinbased skeleton is composed of 100-nm-long ␣, ␤-spectrin heterodimers that associate head-tohead into tetramers, which, in turn, assemble into a hexagonal lattice on the cytoplasmic surface of the membrane. This spectrin skeleton is attached to the membrane both at a junctional complex, where it associates with actin and other proteins, and near the center of each spectrin tetramer, where ankyrin forms a bridge to the anion exchanger, band 3. Although noncanonical domains exist within each spectrin tetramer, most of the tetramer is composed of 74 triple helical repeats of 106 amino acids each of which are connected to one another by an ordered continuous helix. Proteins such as ankyrin, the Lutheran blood group antigen, N-CAM, EAAT4, and NMDA-R2 bind to these spectrin repeats, 1 but unfortunately, the conformational requirements for these interactions have not been elucidated.
In this issue of Blood, both Stabach et al 2 and Ipsaro et al 3 independently perform mapping of the ankyrin-spectrin interaction using largely nonoverlapping approaches. While both groups solve the crystal structure of repeats 14 and 15 of ␤-spectrin, Ipsaro et al attempted to identify the ankyrin binding site on ␤-spectrin by separately solving the crystal structure of a spectrinbinding fragment of ankyrin (residues 911-1068) and then examining the 2 crystal structures for charge and shape complementarity. While no obvious shape complementarity emerged, Ipsaro et al noted a patch of anionic amino acids within and adjacent to helix C of spectrin repeat 14 that matched up well with cationic amino acids in the crystallized fragment of ankyrin.
In contrast, Stabach et al elected to locate the ankyrin binding site on their crystal structure of the ␤-spectrin repeats by performing site-directed mutagenesis. Upon mutation of 42 carefully selected residues, they identified 14 amino acids whose mutagenesis either abrogated or compromised ankyrin binding. Importantly, several of the identified residues coincided with the anionic residues hypothesized by Ipsaro et al to comprise the ankyrin binding site. Other critical residues resided either in the linker connecting the spectrin repeats or within a loop spanning helices B and C of repeat 15.
It is the function of this latter loop that gives rise to an important distinction between the 2 papers. Stabach et al hypothesize that these loop-spanning residues control the tilt angle between ␤-spectrin repeats 14 and 15. Thus, unlike any other spectrin repeat structure published to date, 4 observe a 64°bend between the 2 spectrin repeats, and hypothesize that the pocket formed by this bend provides many of the highaffinity contacts involved in ankyrin binding. Ipsaro et al, in contrast, see no such bend, but they do observe crystallographic evidence for considerable flexibility within this region, suggesting that the linker could be flexible and that the spectrin conformer immobilized in their crystal structure assumes a nonbent conformation. Possible resolution of this discrepancy can be found in a recent online article by Davis et al 5 that describes the crystal structure of the ankyrin binding domain (repeats 14-16) of ␤2-spectrin as having a bent structure. As observed by Stabach et al, Davis et al also find that differences in interrepeat contacts, involving an homologous loop in ␤2-spectrin, may be responsible for the unusual bend seen in the 2-repeat structure that binds ankyrin.
In summary, a possible unifying interpretation that emerges from all of the data are that acidic amino acids near the C-terminus of helix C in repeat 14, together with the linker connecting repeat 14 to repeat 15 and the loop linking helices B and C of repeat 15, all contribute to formation of a flexible pocket on spectrin that associates with ankyrin. Because defects in the spectrin-ankyrin function are associated with such human pathologies as hereditary spherocytosis, cardiac arrhythmia, premature aging, deafness, and ataxia, 6 further examination of this very important membrane complex is clearly warranted. ---------------------------------------------------------------------------------------------------------------- 
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A team player: the disintegrin domain of ADAMTS13
X. Long Zheng CHILDRENЈS HOSPITAL OF PHILADELPHIA
In this issue of Blood, de Groot and colleagues identify novel interactions between the disintegrin domain of ADAMTS13 and the A2 domain of VWF. This provides another piece in the puzzle of how this domain of ADAMTS13 works in concert with other domains to bind and process VWF.
A DAMTS13, a member of A disintegrin and metalloprotease with thrombospondin type 1 repeats (ADAMTS) family, 1,2 is a multidomain glycoprotein found in plasma. 3 It consists of numerous domains including a metalloprotease domain, a disintegrin domain, first thrombospondin type 1 (TSP1) repeat, a cysteine-rich domain, and a spacer domain (see panel A in the figure). These are followed by 7 more TSP1 repeats and 2 CUB (complement c1r/c1s, sea urchin epidermal growth factor, and bone morphogenetic protein) domains (figure panel A).
ADAMTS13 makes a precise cut on the von Willebrand factor (VWF) molecule after the amino acid residue Tyr 1605 at the central A2 domain. This proteolytic cleavage is essential to reduce the size of VWF polymers so that they remain functional enough to stop bleeding, but not so sticky as to cause unwanted thromboses in the small arterioles. 4, 5 However, it is still unclear how each of the ADAMTS13 
